Status:
COMPLETED
Evaluation of Lung Ultrasound in Acute Heart Failure
Lead Sponsor:
Prof. Dr. Jörg Leuppi
Conditions:
Acute Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Acute heart failure is a life threatening condition requiring rapid diagnosis and treatment. However, the differentiation between heart failure and other conditions presenting with acute dyspnea is no...
Detailed Description
Evaluation of Lung Ultrasound in Acute Heart Failure (ELUSIA). A monocenter, randomised, double-blind, diagnostic clinical study. Background and Rationale: Acute heart failure is a life threatening c...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Emergency room presentation with acute dyspnoe as principal complaint (either new or worsening in the last 48 hours) Age ≥18 years.
- Exclusion criteria:
- Immediately life threatening condition (cardiac arrest, ST-elevation myocardial infarction, shock, respiratory failure requiring intubation) No consent.
Exclusion
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03243773
Start Date
March 1 2016
End Date
September 30 2018
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cantonal Hospital Baselland
Bruderholz, Basel-Landschaft, Switzerland, 4101